Medindia

X

Enzyme Developed from Corn can Reduce Cost of Treating Life-Threatening Inherited Disease

by Kathy Jones on  September 20, 2012 at 7:42 PM Genetics & Stem Cells News   - G J E 4
Canadian biologists revealed that they have developed a new medical enzyme through genetically engineered corn that could be used to reduce the cost of treating a life-threatening inherited disease.
 Enzyme Developed from Corn can Reduce Cost of Treating Life-Threatening Inherited Disease
Enzyme Developed from Corn can Reduce Cost of Treating Life-Threatening Inherited Disease
Advertisement

Inserting a section of DNA code into maize seed caused them to make alpha-L-iduronidase in the endosperm, a nutritive tissue in the corn kernel.

Advertisement
Alpha-L-iduronidase breaks down sugar molecules and is deficient in people with mucopolysaccheridosis I (MPS 1).

This is a so-called lysosomal storage disorder, in which sugary debris builds up in cells, damaging tissue in the heart, eyes, skeleton and brain.

Without replacement enzymes, sufferers of MPS 1 often die in childhood.

Until now, the therapy has been produced by coaxing cultures of cells taken from the ovaries of Chinese hamsters, and is hugely expensive.

The existing drug for MPS 1, laronidase (marketed as Aldurazyme) costs around $300,000 annually for children and $1 million for adults.

The research, led by Allison Kermode at Simon Fraser University in Burnaby, British Columbia, is published in the journal Nature Communications.

The results amount to "proof of concept" for making the enzyme in laboratory conditions, the team say.

Further work would be needed to scale up volume, but this should not be too much of a problem and conventional techniques could be used, they add.

Severe MPS I occurs in approximately in one in 100,000 newborns, according to the website Genetics Home Reference, which is supported by the US health authorities.

A milder form, called attenuated MPS I, occurs in about one in 500,000 births.

Source: AFP
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All